CMTx Biotech is a clinical-stage biopharmaceutical company that is developing an orally administered small molecule for the treatment of sepsis patients at risk of Acute Respiratory Distress Syndrome (ARDS) and/or Multiple Organ Dysfunction Syndrome (MODS), including those infected with SARS-CoV-2 (COVID-19).

Biotechnology

CMTx Biotech

Joseph Scaduto

Joann Wilson

James Keane

Christopher Czura

Lorne Golub

Sonny Granger

The executive team at CMTx Biotech has a history of working in strategy, investments, business development, and management. They have also been educated at some of the top institutions in the country, including Harvard Business School, the University of Virginia, and Columbia Business School.

CEO and Executive Team

Board of Directors

Leadership Team

Founding Team

CEO and Executive Team

About

Team members

Other teams at CMTx Biotech

Board of Directors

Leadership Team

Founding Team